LOBEF (Lobe Sciences) Long-Term Debt: $0.23 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LOBEF Lobe Sciences Ltd LOBEF
16 GF Score
Price $0.08
! 2 Warning Signs
View Full Analysis

What is Lobe Sciences Long-Term Debt?

Lobe Sciences LOBEF -2.44% 16 Long-Term Debt is $0.23 Mil as of Feb. 2026. GuruFocus rates LOBEF with a GF Score™ of 16/100. The stock has 2 warning signs investors should review.

Lobe Sciences's Long-Term Debt for the quarter that ended in Feb. 2026 was $0.23 Mil.

Lobe Sciences's quarterly Long-Term Debt increased from Aug. 2025 ($0.20 Mil) to Nov. 2025 ($0.21 Mil) and increased from Nov. 2025 ($0.21 Mil) to Feb. 2026 ($0.23 Mil).

Lobe Sciences's annual Long-Term Debt increased from Aug. 2023 ($0.00 Mil) to Aug. 2024 ($0.81 Mil) but then declined from Aug. 2024 ($0.81 Mil) to Aug. 2025 ($0.20 Mil).

Lobe Sciences  (OTCPK:LOBEF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Lobe Sciences Long-Term Debt Related Terms

Lobe Sciences Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Lobe Sciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences Long-Term Debt Chart

Lobe Sciences Annual Data
Trend Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.81 0.20

Lobe Sciences Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 1.32 0.20 0.21 0.23
LOBEF
16GF Score
Lobe Sciences Ltd LOBEF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.23 Mil mean?
Lobe Sciences (LOBEF) has a Long-Term Debt of $0.23 Mil as of Feb. 2026.
Is Lobe Sciences' Long-Term Debt too high?
Lobe Sciences' current Long-Term Debt is $0.23 Mil. Overall, Lobe Sciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Lobe Sciences' Long-Term Debt compare to VRTX and REGN?
Lobe Sciences' Long-Term Debt of $0.23 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Lobe Sciences's current Long-Term Debt is $0.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current Long-Term Debt of $0.23 Mil. The current Long-Term Debt is $0.23 Mil. Lobe Sciences' overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current Long-Term Debt is $0.23 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lobe Sciences Business Description

Other Exchanges LOBE:GermanyLOBE:Canada
Address 1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.
16GF Score

Get the complete analysis for LOBEF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price